U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 1-7, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 1-7, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 10/02/2023
Location: Bethesda, MD
Subject: GRx+Biosims 2023
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, and media

Event Date: 10/03/2023
Location: Washington, DC
Subject: Future of Health Data Summit: Regulating the Future; FDA's Role in Powering Innovation From Bench to Bedside
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, and government

Event Date: 10/04/2023
Location: Virtual
Subject: Council for Responsible Nutrition (CRN) Annual Executive Conference: Now, New, Next
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, and media

Event Date: 10/05/2023
Location: Virtual
Subject: Reagan-Udall Foundation Meeting; Strategies for Improving Public Understanding of FDA-Regulated Products
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, and media

Event Date: 10/05/2023
Location: Virtual
Subject: Meeting with Cancer Centers
FDA Participant/Group: JULIA TIERNEY; HILARY MARSTON; MICHELLE ADAMS;
Non FDA Participant/Group: Government and academia

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 10/03/2023
Location: Montreal, Canada
Subject: Regulatory Affairs Professionals Society (RAPS) Conference 2023; Panelist: The Futuristic Regulatory Professional
FDA Participant/Group: N/A
Non FDA Participant/Group: Participants representing industry, global regulatory bodies, and research, academic and clinical organizations directly involved in managing regulatory process and aligning science, regulation and business stragegy.

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 10/02/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Barbara Kowalcyk (George Washington University);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/05/2023
Location: Washington, DC
Subject: 20th Annual International Federation for Adipose Therapeutics and Science Conference; Adipose Stem Cells: Turning the Hype into High-End Medical Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and medical stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 10/02/2023
Location: Virtual
Subject: Meeting with Center for Science in the Public Interest (CSPI); Sesame Allergen Labeling
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Christine Olsen (Food Allergy Science Initiative); Mary Jo Strobel (American Partnership for Eosinophilic Disease); Thomas Silvera (Elijah-Alavi Foundation ); Eleanor Garrow-Holding (Food Allergy & Anaphylaxis Connection Team); Jason Linde, Robert Earl (Food Allergy Research Education ); Kenny Mendez; Jenna Riemenschneider (Asthma and Allergy Foundation of America ); Ellyn Kodroff (Campaign Urging Research for Eosinophilic Disease); Charmayne Anderson (Allergy & Asthma Network); Peter Lure; Sarah Sorscher; James Kincheloe (Center for Science in the Public Interest ); Toni Taylor (Allergy Advocacy Association ); Erin Malawer (AllergyHealth );

Event Date: 10/05/2023
Location: Crystal City, Virginia
Subject: Food Marketing Inc (FMI) Meeting; Update on FDA Priorities, Front of Package Labeling, Food Traceability Rule, and Closer to Zero
FDA Participant/Group: N/A
Non FDA Participant/Group: Ryan Redford (Amazon Inc); Erica Baum (General Mills); Abel Martine (H-E-B); Justin Evans (Giant Eagle, Inc); Stacey Johnson; Anne Roth (Hy-Vee); Reece Langley (Langley, LLC); Samantha Summers (Albertsons Companies); Several Members from FMI (FMI); Kate Brown, Emma Bryan; Lucas Szabo (Nestle USA); Pat Maloney (Danone North America); Bryan Granger (C&S Wholesale Grocers ); Steve Brophy (Dollar General Corportation );

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 10/03/2023
Location: Virtual
Subject: Medical University of South Carolina (MUSC) Call; FDA’s Regulatory Strategy for Tobacco Ad Nicotine
FDA Participant/Group: MATTHEW FARRELLY;
Non FDA Participant/Group: Several staff and attendees of the Medical University of South Carolina (MUSC)

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top